Copyright
©The Author(s) 2023.
World J Gastroenterol. Jan 7, 2023; 29(1): 157-170
Published online Jan 7, 2023. doi: 10.3748/wjg.v29.i1.157
Published online Jan 7, 2023. doi: 10.3748/wjg.v29.i1.157
Ref. | Patients with insulinoma, n | Mean time (range) of clinical follow-up in mo | Mean time (range) of radiological follow-up in mo |
Lakhtakia et al[12] | 3 | 11.7 (11-12) | 4.2 (1.5-8) |
Waung et al[21] | 1 | 10 | 3 d |
Bas-Cutrina et al[22] | 1 | 10 | 10 |
Choi et al[25] | 1 | NR | NR |
Oleinikov et al[14] | 7 | 9.7 (3-21) | 8.7 (2-21) |
Rossi et al[30] | 3 | 22 (14-27) | 5.7 (3-14) |
Chang et al[27] | 1 | 18 | 18 |
Kluz et al[28] | 1 | NR | NR |
Furnica et al[29] | 4 | 22 (13-28) | 8 (3-14) |
Marx et al[15] | 7 | 21 (3-38) | 20.3 (3-38) |
- Citation: Khoury T, Sbeit W, Napoléon B. Endoscopic ultrasound guided radiofrequency ablation for pancreatic tumors: A critical review focusing on safety, efficacy and controversies. World J Gastroenterol 2023; 29(1): 157-170
- URL: https://www.wjgnet.com/1007-9327/full/v29/i1/157.htm
- DOI: https://dx.doi.org/10.3748/wjg.v29.i1.157